首页> 外文期刊>Oncology letters >Novel peptide screened from a phage display library antagonizes the activity of CC chemokine receptor 9
【24h】

Novel peptide screened from a phage display library antagonizes the activity of CC chemokine receptor 9

机译:从噬菌体展示库中筛选的新型肽拮抗CC趋化因子受体9的活性

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

CC chemokine receptor 9 (CCR9) serves a role in the drug resistance and metastasis of tumors. In the present study, a peptide specifically bound to CCR9 was obtained and the effect on tumor cells was observed. A Ph.D.-12 phage display peptide library was used to screen for peptides binding specifically to the second extracellular loop of CCR9. The ratios of the input and output of phage clones increased gradually following three rounds of biopanning. A total of 8 positive phage clones were identified from DNA analysis. A phage clone, C-4, was identified which exhibited higher affinity and specificity for the second extracellular loop of CCR9 in vitro compared with other clones. A peptide (P1; VHWDFRQWWQPS) was identified which may inhibit the corresponding phage, C-4, binding to the second extracellular loop of CCR9. Furthermore, P1 was able to bind specifically with MOLT4 cells which exhibit marked expression of CCR9. In addition, P1 promoted the apoptosis of MOLT4 cells induced by doxorubicin, and inhibited the migration of MOLT4 cells in the presence of chemokine (C-C motif) ligand 25. It was suggested that decreased activity in the phosphorylation of protein kinase B in MOLT4 cells may be responsible for the inhibition. In conclusion, the peptide P1 derived from a screened phage is able to specifically bind to CCR9 and inhibit the activity of CCR9. It has potential use as an antagonist in the treatment of CCR9-overexpressed carcinoma.
机译:CC趋化因子受体9(CCR9)在肿瘤的耐药和转移方面发挥作用。在本研究中,获得特异于CCR9的肽,观察到对肿瘤细胞的影响。 pH.D.-12噬菌体展示肽库用于筛选特异性的CCR9细胞外环的肽。噬菌体克隆的输入和输出的比率逐渐增加了三轮生物丙次术后。从DNA分析中鉴定了总共8个阳性噬菌体克隆。鉴定了噬菌体克隆,C-4,其与其他克隆相比,对体外CCR9的第二个细胞外环的亲和力和特异性表现出更高的亲和力和特异性。鉴定肽(P1; VHWDFRQWWQPS),其可抑制对应的噬菌体C-4,与CCR9的第二个细胞外环结合。此外,P1能够特别用莫特4细胞结合,所述MOLT4细胞表现出CCR9的标记表达。此外,P1促进了多柔比星诱导的MOLT4细胞的凋亡,并抑制MOLT4细胞在趋化因子(CC基序)配体25存在下的迁移。建议在MOLT4细胞中蛋白激酶B的磷酸化中的活性降低负责抑制作用。总之,衍生自筛选噬菌体的肽P1能够特异性结合CCR9并抑制CCR9的活性。它具有潜在用作CCR9过表达癌的拮抗剂。

著录项

  • 来源
    《Oncology letters》 |2017年第3期|共6页
  • 作者单位

    Xiamen Univ Affiliated Hosp 1 Dept Lab Med 55 Zhenhai Rd Xiamen 361003 Fujian Peoples R China;

    Xiamen Univ Affiliated Hosp 1 Dept Resp Med Xiamen 361003 Fujian Peoples R China;

    Xiamen Univ Affiliated Hosp 1 Dept Orthoped Xiamen 361003 Fujian Peoples R China;

    Jimei Univ Coll Food &

    Biol Engn Xiamen 361021 Fujian Peoples R China;

    Xiamen Univ Affiliated Hosp 1 Dept Lab Med 55 Zhenhai Rd Xiamen 361003 Fujian Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

    CC chemokine receptor 9; peptide; tumor; antagonist; apoptosis; migration;

    机译:CC趋化因子受体9;肽;肿瘤;拮抗剂;细胞凋亡;迁移;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号